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TIMING CONTROL FOR PAIRED
PLASTICITY
PRIORITY CLAIM
Thepresentapplication is a continuation ofapplication Ser.
No. 13/941,986,filed Jul. 15, 2013, entitled TIMING CON-
TROL FOR PAIRED PLASTICITY, whichis a division of
application Ser. No. 12/485,857, filed Jun. 16, 2009, entitled
TIMING CONTROL FOR PAIRED PLASTICITY, whichis
a continuation application of U.S. Utility patent application
Ser. No. 12/485,040,filed Jun. 15, 2009 and claimspriority
benefits under 35 U.S.C. §119(e) from Provisional Applica-
tion No. 61/077,648,filed on Jul. 2, 2008 and entitled “Treat-
ment of Tinnitus withVagus Nerve Stimulation”; U.S. Provi-
sional Application No. 61/078,954, filed on Jul. 8, 2008 and
entitled “Neuroplasticity Enhancement”; U.S. Provisional
Application No. 61/086,116, filed on Aug. 4, 2008 and
entitled “Tinnitus Treatment Methods and Apparatus”; and
USS. Provisional Application No. 61/149,387, filed on Feb.3,
2009 andentitled “Healing the Human Brain: The Next Medi-
cal Revolution.” The present application incorporates the
foregoing disclosures herein by reference.
BACKGROUND
The present disclosure relates generally to therapy, reha-
bilitation and training including inducedplasticity. More par-
ticularly, the disclosure relates to methods and systems of
enhancing therapy, rehabilitation and training using nerve
stimulation paired with training experiences.
SUMMARY
For purposes of summarizing the invention, certain
aspects, advantages, and novelfeatures ofthe invention have
been described herein.It is to be understood that not neces-
sarily all such advantages may be achieved in accordance
with any particular embodimentof the invention. Thus, the
invention may be embodiedor carried out in a mannerthat
achieves or optimizes one advantage or group of advantages
as taught herein without necessarily achieving other advan-
tages as may be taught or suggested herein.
BRIEF DESCRIPTION OF THE DRAWINGS
The disclosed inventions will be described with reference
to the accompanying drawings, which show important
sample embodiments ofthe invention and whichare incorpo-
rated in the specification hereof by reference, wherein:
FIG. 1 is a block diagram depicting a paired training sys-
tem, in accordance with an embodiment;
FIG.2 is a block diagram depicting a paired training sys-
tem affecting a sub-cortical region, in accordance with an
embodiment;
FIG.3 is a block diagram depicting a paired training sys-
tem affecting the nucleus basalis, in accordance with an
embodiment;
FIG.4 is a block diagram depicting a paired training sys-
tem affecting the locus coeruleus, in accordance with an
embodiment;
FIG. 5 is a block diagram depicting a paired training sys-
tem affecting the amygdala, in accordance with an embodi-
ment;
FIG.6 is a block diagram depicting a paired training sys-
tem affecting the nucleusofthe solitary tract (NTS), in accor-
dance with an embodiment;
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FIG.7 is a block diagram depicting a paired training sys-
tem affecting the cholinergic system, in accordance with an
embodiment;
FIG.8 is a block diagram depicting a paired training sys-
tem affecting the noradrenergic system, in accordance with
an embodiment;
FIG. 9 is a simplified diagram depicting a stimulator, in
accordance with an embodiment;
FIG. 10 is a simplified diagram depicting a wireless stimu-
lator, in accordance with an embodiment;
FIG. 11 is a simplified diagram depicting a dual stimulator
configuration, in accordance with an embodiment;
FIG. 12 is a simplified diagram depicting a multi-stimula-
tor configuration, in accordance with an embodiment;
FIG.13 is a graph depicting a constant current stimulation
pulse, in accordance with an embodiment;
FIG. 14 is a graph depicting an exponential stimulation
pulse, in accordance with an embodiment;
FIG. 15 is a graph depicting a train of constant current
stimulation pulses, in accordance with an embodiment;
FIG.16 is a block diagram depicting a synchronizing con-
trol system, in accordance with an embodiment;
FIG. 17 isa graph depicting synchronized pairing,in accor-
dance with an embodiment;
FIG. 18 is a block diagram depicting a response control
system, in accordance with an embodiment;
FIG. 19 is a graph depicting response pairing, in accor-
dance with an embodiment;
FIG. 20 is a block diagram depicting a manual control
system, in accordance with an embodiment;
FIG.21 is a graph depicting manual pairing, in accordance
with an embodiment;
FIG.22 is a block diagram depicting a closed loop control
system, in accordance with an embodiment;
FIG.23 is a graph depicting closed loop pairing, in accor-
dance with an embodiment;
FIG. 24 is a block diagram depicting an initiated control
system, in accordance with an embodiment;
FIG. 25 is a graph depicting initiated pairing, in accordance
with an embodiment;
FIG. 26 is a block diagram depicting a delayed response
timing control system, in accordance with an embodiment;
and
FIG. 27 is a graph depicting delayed response pairing, in
accordance with an embodiment.
DETAILED DESCRIPTION OF THE DRAWINGS
The numerousinnovative teachingsofthe present applica-
tion will be described with particular reference to presently
preferred embodiments (by way ofexample, and not of limi-
tation). The present application describes several inventions,
and noneofthe statements below should be taken as limiting
the claims generally. Where block diagrams have been used to
illustrate the invention,it should be recognizedthat the physi-
cal location where described functions are performedare not
necessarily represented by the blocks. Part of a function may
be performed in one location while anotherpart of the same
function is performed at a distinct location. Multiple func-
tions may be performedat the same location.
With referenceto FIG.1, a pairedtraining system is shown.
A timing control system 106 is communicably connected to a
neural stimulator system 108 and a training system 110.
Receiving timing instruction from the timing control system
106, the neural stimulator system 108 provides stimulation to
a nerve 104. Similarly receiving timing instruction from the
timing control system 106, or providing timing instruction to
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the timing control system,the training system 110 generates
desired mental images, ideas, formationsorstates in the brain
102. The stimulation ofthe nerve 104 affects the brain 102 by
inducing plasticity. The temporally paired combination of
training and stimulation generates manifestations ofplastic-
ity in the brain 102 that may be measuredby aplasticity
measure system 112.
The timing controls system 106 generally provides the
simultaneous nature of the pairing. The stimulation and the
training are simultaneousin that they occur at the same time,
that is, there is at least some overlap in the timing. In some
embodiments, the stimulation mayleadthe start of the train-
ing while in other embodiments, the stimulation may follow
the start of the training. In many cases, the stimulation is
shorter in duration than the training, suchthat the stimulation
occurs near the beginning ofthetraining.Plasticity resulting
from stimulation has been shownto last minutes or hours, so
a single stimulation pulse may suffice for the whole duration
of extendedtraining.
In the treatmentof tinnitus, for example, the training may
consist ofbriefaudible sounds including selected therapeutic
frequencies, paired with stimulations. Because the duration
ofthe sounds maybeshort, the timing may be controlled very
precisely so that the sound coincides temporally with the
stimulation. This kind of precision may typically require
some form of computer control. In other forms of rehabilita-
tion or education, the timing ofthe training and/orthe stimu-
lation may be controlled manually. Further therapies and
training may include training triggered timing or physical
condition feedback to provide a closed-loop system.
The neural stimulation system 108 may provide stimula-
tion of the nerve 104 using electrical stimulation, chemical
stimulation, magnetic stimulation, optical stimulation,
mechanical stimulation or any other form of suitable nerve
stimulation. In accordance with an embodiment, an electrical
stimulation is provided to the left vagus nerve. In anelectrical
stimulation system, suitable stimulation pulses may include a
variety ofwaveforms, including constant current pulses, con-
stant voltage pulses, exponential pulses or any other appro-
priate waveform.An electrical stimulation system may use a
single stimulation pulse or a train of stimulation pulses to
stimulate the nerve 104. Stimulation parameters are selected
to affect the brain 102 appropriately, with reference to the
affected brain regions or systems,plasticity measures, desyn-
chronization or any other appropriate stimulation parameter
measure. A half second train of biphasic stimulation pulses,
with a pulse width of 100 microseconds,at 0.8 milliamps and
at 30 Hz has been usedeffectively in the treatmentoftinnitus.
Paired stimulation could be accomplished using deep brain
stimulation, cortical stimulation, transcranial magnetic
stimulation and any other suitable neural stimulation.
One indication of appropriate stimulation may be desyn-
chronization of the cortical EEG. A 0.8 milliamp pulse has
been shown to cause cortical desynchronization at frequen-
cies between 30 and 150 Hz.0.4 milliamp pulses desynchro-
nizethe cortex at higher frequencies of 100 to 150 Hz. Desyn-
chronization has been shownto last for at least four seconds
in response to stimulation of the vagus nerve.
The simultaneoustraining system 110 generates the sen-
sory input, motor sequences, cognitive input, mental images,
ideas, formationsor states that are to be retained by the brain
102. A training system 110 may provide sensory information,
such asvisual, auditory, olfactory, tactile or any other suitable
sensory information. Training system 110 mayinclude physi-
cal therapies, cognitive therapies, emotional therapies,
chemical therapies, or any other suitable therapies. Training
system 110 may present educational information. Training
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system 110 may include the subject, physically, mentally,
emotionally or in any other suitable fashion. Training system
110 may include teachers, doctors, therapists, counselors,
instructors, coaches or any other suitable training provider.
Training system 110 may evoke specific patterns of neural
activity by direct brain stimulation, for example byelectrical,
magnetic, optical, or any other suitable pattern evocation
systems. Training system 110 mayinactivate specific brain
regions via chemical agents, cooling, magnetic stimulation,
or other suitable methods.
The paired training system of FIG. 1 affects the brain 102
to generate plasticity that can be measured by plasticity
measure system 112. In the treatment of tinnitus, a cortical
map maybe used to measure the map distortion and correc-
tion that accompanies the successful treatment of tinnitus.
Less invasively, the plasticity can be measured by behavior-
ally reactions to stimuli, such as startle test for tinnitus.
Further, plasticity can be measured by inquiring about the
subjective experience of a subject. If a tinnitus patient no
longer experiencesa persistent noise, plasticity has beenmea-
sured.
With reference to FIG.2, a paired training system affecting
a subcortical region 114 of the brain 102, in accordance with
an embodiment is shown. The stimulation of nerve 104
affects a subcortical region 114. The subcortical region 114,
in turn, affects the brain to induce plasticity. Stimulation of
nerves 104 such as the trigeminal nerve and other cranial
nerves are knownto affect the subcortical region 114.
With reference to FIG.3, a paired training system affecting
the nucleus basalis 116, in accordance with an embodiment,
is shown. The stimulation of nerve 104 affects the nucleus
basalis 116. The nucleus basalis, in turn, affects the brain 102
to induceplasticity.
With reference to FIG.4, a paired training system affecting
the locus coeruleus 118, in accordance with an embodiment,
is shown. The stimulation of nerve 104 affects the locus
coeruleus 118. The locus coeruleus 118, in turn, affects the
brain 102 to induceplasticity.
With reference to FIG.5,a paired training system affecting
the amygdala 120, in accordance with an embodiment, is
shown. The stimulation of nerve 104 affects the amygdala
120. The amygdala 120, in turn, affects the brain 102 to
induceplasticity.
With reference to FIG.6, a paired training system affecting
the NTS 122, in accordance with an embodiment, is shown.
Thestimulation of nerve 104 affects the NTS 122. The NTS
122, in turn, affects the brain 102 to induceplasticity.
With reference to FIG.7, a paired training system affecting
the cholergenic system 124, in accordance with an embodi-
ment, is shown. The stimulation of nerve 104 affects the
cholergenic system 124. The cholergenic system 124 releases
acetylcholine (ACh) into the brain 102 inducingplasticity.
With reference to FIG.8, a paired training system affecting
the noradrenergic system 126, in accordance with an embodi-
ment, is shown. The stimulation of nerve 104 affects the
noradrenergic system 126. The noradrenergic system 126
releases noradrenaline (NE) into the brain 102 inducing plas-
ticity.
With reference to FIG. 9, a neural stimulator system, in
accordance with an embodiment, is shown. A neural stimu-
lator control 109 is communicably connected to a neuro-
stimulator 128. Neurostimulator 128 provides a stimulation
pulse to a nerve 104 via a pair of electrodes 130a and 1305.
Electrodes 103a and 1306 could be cuff electrodes, conduc-
tive plates or any other suitable neural stimulation electrode.
The neurostimulator may be poweredby a piezoelectric pow-
ering system as well as near field inductive powertransfer,
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far-field inductive powertransfer, battery, rechargeable bat-
tery or any other suitable neurostimulator power system.
When neural stimulator control 109 receives timing instruc-
tions from a timing control system (not shown), the neural
stimulator control 109 initiates a stimulation pulse from the
neurostimulator 128 via electrodes 130a and 1308.
With reference to FIG. 10, a wireless neural stimulator
system, in accordance with an embodimentis shown. Neuro-
stimulator 128 communicates with the neural stimulation
system 109 using an inductive transponder coil 132. The
neural stimulator system 109 includes an external coil 134.
Information may be communicated betweenthe neural stimu-
lator system 109 and the neurostimulator 128. Power may be
transferred to the neurostimulator 128 by the neural stimula-
tor system.
With reference to FIG. 11, a dual neurostimulator system,
in accordance with an embodiment, is shown. Two neuro-
stimulators 128 may stimulate neural 104. The neurostimu-
lators may be controlled to reinforce each other, as redun-
dancy, or to prevent efferent signals from projecting away
from the brain.
With reference to FIG. 12, a multi-neurostimulator system,
in accordance with an embodiment, is shown. A plurality of
neurostimulators 128 may stimulate nerve 104. The neuro-
stimulators may be controlled to reinforce each other, as
redundancy, or to prevent efferent signals from projecting
away from the brain.
With reference to FIG. 13, a graph shows a constant current
stimulation pulse, in accordance with an embodiment.
With reference to FIG. 14, a graph shows an exponential
stimulation pulse, in accordance with an embodiment.
With reference to FIG. 15, a graph showsa train ofconstant
current stimulation pulses, in accordance with an embodi-
ment.
With reference to FIG. 16, a synchronized timing control
system, in accordance with an embodiment, is shown. The
synchronized timing control system includes a synchronizing
timing control 186. The synchronizing timing control 186 is
communicably connected to the neural stimulation system
108 and the training system 110. The synchronizing timing
control 136 provides timing instructions to the neural stimu-
lation system 108 and the training system 110 so that the
stimulation and training occur simultaneously. In the treat-
ment of tinnitus, the stimulation of the nerve may slightly
precedes each training sound,to give the stimulation time to
affect the brain whenthe training soundis presented. Further
embodiments may include other suitable timing variations.
With reference to FIG. 17, a graph showsa possible timing
relationship between event and stimulation for a synchro-
nized timing control system.
With reference to FIG. 18, a response timing control sys-
tem, in accordance with an embodiment, is shown. The
response timing control system includes a response timing
control 138. The response timing control 138 is communica-
bly connected to the neural stimulation system 108 and a
simultaneous event monitor 140. The response timing control
138 receives timing instructions from the event monitor 140
and provides timing instructions to the neural stimulation
system 108, so that the stimulation and training occur simul-
taneously. Becausethe stimulation 1s generated in response to
an event, the stimulation will generally lag the event by some
finite time delta t. In cases where there is an event precursor
that can be monitored, the timing can be made moreexact.
With reference to FIG. 19, a graph showsa possible timing
relationship between a monitored event and a nerve stimula-
tion.
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With reference to FIG. 20, a manualtiming control system,
in accordance with an embodiment, is shown. The manual
timing control system includes a response timing control 138.
The response timing control 138 is communicably connected
to the neural stimulation system 108 and a manualinput 142.
The response timing control 138 receives timing instructions
from the manualinput 142 and providestiming instructions to
the neural stimulation system 108,so that the stimulation and
training occur simultaneously.
With reference to FIG. 21, a graph showsa possible timing
relationship between an event, a manual input and a neural
stimulation.
With reference to FIG. 22, a closed loop timing control
system, in accordance with an embodiment, is shown. The
closed loop timing control system includes a closed loop
timing control 144. The closed loop timing control 138 is
communicably connected to the neural stimulation system
108 and a sensor 146. The closed loop timing control 144
receives timing instructions from the sensor 146 and provides
timing instructions to the neural stimulation system 108, so
that the stimulation and training occur simultaneously.
With reference to FIG. 23, a graph showsa possible timing
relationship between an sensed training event and a neural
stimulation is shown.
Sensor 146 may monitor externalor internal events, includ-
ing heart-rate, blood pressure, temperature, chemical levels
or any other parameter that may indicate a training event.
With reference to FIG. 24, a initiated timing control sys-
tem, in accordance with an embodiment, is shown. Theiniti-
ated timing control system includes an initiated timing con-
trol 148. The initiated timing control 148 is communicably
connected to a neural stimulation system 106 and an event
generator 150. Theinitiated timing control 148 receives tim-
ing information from the neural stimulation system 106, indi-
cating that a nerve has been stimulated. The initiated timing
control 148 provides timing instructions to the event genera-
tor 150, such as a therapeutic sound generator connected by
Bluetooth, such that the event generator 150 generates an
event during the stimulation pulse.
With reference to FIG. 25, a graph showsa possible timing
relationship between a neural stimulation and an event gen-
eration.
With reference to FIG. 26, a delayed response timing con-
trol system, in accordance with an embodiment, is shown.
The delayed response timing control system includes an
delayed response timing control 152. The delayed response
timing control 152 is communicably connected to a neural
stimulation system 106 and a preliminary event sensor 154.
The preliminary event sensor 154 detects a preliminary event
that anticipates a pairing event. The delayed response timing
control 148 receives timing information from the preliminary
event sensor 154,indicating that a preliminary event has been
detected. The delay response timing control 148 provides
timing instructions to the neural stimulation system 106 to
initiate nerve stimulation. In the depicted embodiment, the
timing control 152 initiates the stimulation before the begin-
ning of the pairing event, giving a negative delta t. A delay
response timing system mayinitiate stimulation at the same
time as the beginning ofthe pairing event, or after the begin-
ning of the pairing event.
With reference to FIG. 27, a graph showsa possible timing
relationship between a neural stimulation, a preliminary
event and a pairing event.
Theplasticity induced by neural stimulation can be paired
with a variety of therapies, rehabilitation, training and other
formsofpersonal improvement. Each therapyacts asa train-
ing source. The specific timing requirements associated with
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each therapy are derived from the specifics of the therapy,
such thatthe stimulation occurs during the training, and most
effectively near the beginningofthe training. Somepossible
therapies may include behavioral therapies such as sensory
discrimination for sensory deficits, motor training for motor
deficits, with or without robotic assistance and cognitive
training/rehabilitation for cognitive deficits. Exercise and
motor therapy could be paired to treat motor deficits arising
from traumatic brain injury, stroke or Alzheimer’s disease
and movement disorders. Constraint induced therapy could
be paired to help prevent the use of alternative strategies in
order to force use ofimpaired methods. Speech therapy could
be paired for speech and language deficits. Cognitive thera-
pies could be paired for cognitive problems.
Sensory therapies, such as tones, could be pairedto treat
sensory ailments such as tinnitus. In treating tinnitus, the
paired tones may beat frequencies distinct from the frequen-
cies perceived by the tinnitus patient.
Exposure or extinction therapy could be paired to treat
phobiasor post-traumatic stress disorder.
Computer-based therapies such as FastForward for dys-
lexia, Brain Fitness Program Classic or Insight, could be
paired to enhance their effects. Psychotherapy could be
paired, as well as other therapeutic activities in the treatment
of obsessive-compulsive disorder, depression or addiction.
Biofeedback therapy could be paired. For example, tem-
perature readings or galvanic skin responses could be paired
to treat anxiety or diabetes. An electromyograph could be
paired to improve motor control after brain spinal or nerve
damage. A pneumographcould be paired to improvebreath-
ing control in a paralyzed patient. A real-time {MRI could be
paired to improve pain control or treat OCD. An electroder-
mograph, EEG, EMGorelectrocardiograph could be paired
to treat disorders such as anxiety. An electroencephalograph
could be paired to treat epilepsy. An hemoencephalography
could be paired to treat migraines. A photoplethysmograph
could bepaired to treat anxiety. A capnometer could be paired
to treat anxiety. Virtualreality therapy could be paired to treat
disorders such as addiction, depression, anxiety or posttrau-
matic stress disorder. Virtual reality therapy could also be
paired to enhance cognitive rehabilitation or performance.
Drug therapies could be pairedto treat a variety ofconditions.
Amphetamine-like compounds could be paired to enhance
neuromodulators and plasticity. SSRI’s could be paired to
enhance neuromodulators and plasticity. MOA inhibitors
could be paired to enhance neuromodulators andplasticity.
Anti-coagulants could be paired to act as clot busters during
acute stroke. Various drugs couldbe paired to stop spasm after
nerve or brain damage such as Botulinum toxin, Lidocaine,
etc. Small doses of drugs of abuse could be paired to extin-
guish cravings in addicts.
Hormonetherapy could be paired. For example, progest-
erone, estrogen,stress, growth, or thyroid hormone,etc. could
be paired to treat traumatic brain injury or Alzheimer’sdis-
ease. Glucose therapy could be pairedto treat anxiety. Elec-
trical or magnetic stimulation of the central or peripheral
nervous system could be paired. For example, transcranial
magnetic stimulation could be used to enhance or reduce
activity in a specific brain area and thereby focus the directed
cortical plasticity. Transcutaneous electrical nerve stimula-
tion could be paired to treat chronic pain, tinnitus and other
disorders. Subcutaneouselectrical nerve stimulation could be
paired to treat chronic pain. Stem cell therapy could be paired
to treat disorders such as Parkinson’s disease. Gene therapy
could be paired to treat conditions such as Down’s syndrome,
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Huntington’s disease or fragile X syndrome. Hyperbaric oxy-
gen therapy could be pairedto treat carbon monoxide poison-
ing
Multiple therapies could be paired simultaneously or
sequentially.
Noneofthe description in the present application should be
read as implyingthat any particular element, step, or function
is an essential element which must be included in the claim
scope: THE SCOPE OF PATENTED SUBJECT MATTERIS
DEFINED ONLY BY THE ALLOWED CLAIMS. More-
over, none of these claims are intended to invoke paragraph
six of35 USC section 112 unless the exact words “meansfor”
are followed bya participle.
The claimsas filed are intended to be as comprehensive as
possible, and NO subject matter is intentionally relinquished,
dedicated, or abandoned.
Whatis claimedis:
1. A system comprising:
a therapeutic training interface configured to provide tone
based therapy to a patient;
a vagus nerve interface configured to provide electrical
stimulation to a vagus nerveofthe patient, wherein
the system is configured to determine the beginning ofthe
tone based therapy,
the system is configured to control stimulation to the vagus
nerve and controlthe providing ofthe tone based therapy
so that the stimulation to the vagus nerve and the pro-
viding ofthe tone based therapy is synchronized and the
stimulation occurs after the beginning of the tone based
therapy, and
the system is configured to control the therapeutic training
interface and the vagus nerve interface so that at least
one audible toneis providedto the patient followed by a
waiting period followed the providing of at least one
audible tone to the patient and wherein the respective at
least one vagusnerve stimulations are paired with the at
least one audible tones and so that at no audible tones
and no vagusnerve stimulations are provided during the
waiting period.
2. The system of claim 1, wherein:
the system is configured to control the therapeutic training
interface to apply aseries ofaudible tonesto the patient
in synchrony with the stimulation to the vagus nerve.
3. The system of claim 1, wherein:
the system is configured to control the therapeutic training
interface and the vagus nerve interface suchthat at least
one audible toneis providedto the patient followed by a
waiting period followed the providing of at least one
audible tone to the patient and so that respective at least
one vagus nerve stimulationsare paired with the at least
one audible tones.
4. The system of claim 1, wherein:
the system is configured to control the therapeutic training
interface and the vagus nerve interface suchthat at least
one audible toneis providedto the patient followed by a
waiting period followed the providing of at least one
audible tone to the patient and so that respective at least
one vagus nerve stimulationsare paired with the at least
one audible tones and suchthatat least one ofno audible
tones and no vagus nerve stumulations are provided
during the waiting period.
5. The system of claim 1, wherein:
the system is configured to control the therapeutic training
interface and the vagus nerve interface so that stimula-
tion ofthe vagus nerve and providing ofthe audible tone
temporally overlap.
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6. The system of claim 1, wherein:
the system is configured to control the therapeutic training
interface and the vagus nerve interface such that stimu-
lation of the vagus nerve and providing of the audible
tone are paired, and so that the temporal length of the
stimulation of the vagus nerveis different than the tem-
poral length ofthe providing ofthe audible tone to which
the stimulation of the vagus nerveis paired.
7. The system of claim 1, wherein:
the system is configured so that stimulation of the vagus
nerve by the vagus nerve interface is an exponential
stimulation pulse.
8. The system of claim 1, wherein:
the system is configured so that stimulation of the vagus
nerve by the vagus nerve interfaceis a train of discrete
constant current stimulation pulses having a fixed dura-
tion and spacedat fixed intervals.
9. The system ofclaim 1, wherein the system is configured
to control stimulation to the vagus nerve suchthat stimulation
overlaps with the provided tone based therapy.
10. A system comprising:
atiming control system configuredto treat tinnitus therapy
comprising:
a sound generator configured to generate a plurality of
sounds;
a vagus nerve stimulator configured to electrically
stimulate a vagus nerve of a patient, wherein
the timing control system is configured to synchronize
stimulation ofthe vagus nerve with the generation ofthe
plurality of sounds,
the system is configured to identify the respective begin-
nings of the respective generated sounds,
wherein the system configured to provide electrical stimu-
lation of the vagus nerve that respectively begins after
the respective beginnings of the respective generated
sounds, and wherein
the system is configured to synchronize the sounds with
the vagus nerve stimulation so thatat least one sound
is providedto the patient followed by a waiting period
followedbythe providing ofat least one soundto the
patient and wherein respective at least one vagus
nerve stimulations are paired with the at least one
sound and wherein no sound is provided during the
waiting period.
11. The system of claim 10, wherein:
the sound generator is configured to generate sounds,
wherein each sound consists of only one frequency.
12. The system of claim 10, wherein:
the system is configured to control the sound generator to
generate sound randomly.
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13. The system of claim 10, wherein:
the system is configured to control an intensity ofthe sound
generated by the sound generator.
14. The system of claim 10, wherein:
the system is configured to control a duty cycle of a pulse
train of the vagus nerve stimulator so that the vagus
nerve stimulation is followed by a period of non-stimu-
lation at least as long as the length of time of the vagus
nerve stimulation precedent the period of non-stimula-
tion.
15. The system of claim 10, wherein:
the vagus nerve stimulator includes an electrode and a
pulse generator connectedto the electrode.
16. The system of claim 10, wherein the timing control
system is configuredto provide stimulation ofthe vagus nerve
that overlaps with the generation of sound.
17. The system of claim 10, wherein the system is config-
ured to senda seriesofstimulation trigger signals to the vagus
nerve stimulator sothatan electrical pulse train is provided so
that the vagus nerve is stimulated with the electrical pulse
train at the same time as the generation of the plurality of
sounds.
18. The system of claim 10, wherein the system is config-
ured to cause the sound generator to generate the plurality of
sounds randomly.
19. A system, comprising:
a therapeutic training interface configured to provide
soundto a patient;
a vagus nerve interface configured to provide electrical
stimulation to a vagus nerveofthe patient, wherein
the system is configured to control the electrical stimula-
tion to the vagus nerve and control the providing of the
soundso that the stimulation to the vagus nerve and the
providing of the sound is synchronized,
the system is configured to identify the beginning of the
providing of soundto the patient,
the system configured to provide stimulation of the vagus
nerve that begins after the beginning of the provided
sound, and
the system is configured to synchronize the sounds with the
vagus nerve stimulation so thata plurality of respective
sounds are providedto the patient, and wherein the sys-
tem is configured to provide a waiting period between
the respective provided sounds defined by a period
where no sound is provided, and wherein respective at
least one vagus nerve stimulations are paired with the
respective sounds.
* * * * *
